Perfusion Radiology Market Research Report - Global Forecast till 2027

Perfusion Radiology Market: Information by Application (Cardiovascular Imaging, Ventilation Imaging, Brain Imaging, and others), End-User (Hospitals, Diagnostic Centers and others) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6947-CR | October, 2019 | Region : Global

1 EXECUTIVE SUMMARY

1.1 MARKET SYNOPSIS 12

1.2 KEY CONTRIBUTING FACTORS 13

2 MARKET INTRODUCTION

2.1 DEFINITION 14

2.2 SCOPE OF THE STUDY 14

2.3 RESEARCH OBJECTIVE 14

2.4 MARKET STRUCTURE 15

2.5 ASSUMPTIONS & LIMITATIONS 15

3 RESEARCH METHODOLOGY

3.1 DATA MINING 16

3.2 SECONDARY RESEARCH 17

3.3 PRIMARY RESEARCH 18

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 19

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20

3.6.1 BOTTOM-UP APPROACH 21

3.6.2 TOP-DOWN APPROACH 21

3.7 DATA TRIANGULATION 22

3.8 VALIDATION 22

4 MARKET DYNAMICS

4.1 OVERVIEW 23

4.2 DRIVERS 24

4.2.1 GROWING PREVALENCE OF CARDIOVASCULAR AND NEUROLOGICAL DISEASES 24

4.2.2 INCREASING GERIATRIC POPULATION 24

4.2.3 ADVANCEMENTS IN TECHNOLOGY 24

4.3 RESTRAINTS 25

4.3.1 STRINGENT REGULATORY POLICIES 25

4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 25

4.4 OPPORTUNITY 26

4.4.1 ENTERING DEVELOPING ECONOMIES 26

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 27

5.1.1 BARGAINING POWER OF SUPPLIERS 28

5.1.2 BARGAINING POWER OF BUYERS 28

5.1.3 THREAT OF NEW ENTRANTS 28

5.1.4 THREAT OF SUBSTITUTES 28

5.1.5 INTENSITY OF RIVALRY 28

5.2 VALUE CHAIN ANALYSIS 29

5.2.1 R&D AND DESIGNING 30

5.2.2 MANUFACTURING 30

5.2.3 DISTRIBUTION & SALES 30

5.2.4 POST-SALES MONITORING 30

6 PERFUSION RADIOLOGY MARKET, BY APPLICATION

6.1 OVERVIEW 31

6.2 CARDIOVASCULAR IMAGING 32

6.3 VENTILATION IMAGING 33

6.4 BRAIN IMAGING 34

6.5 OTHERS 35

7 PERFUSION RADIOLOGY MARKET, BY END USER

7.1 OVERVIEW 36

7.2 HOSPITALS 37

7.3 DIAGNOSTIC CENTERS 38

7.4 OTHERS 39

8 GLOBAL PERFUSION RADIOLOGY MARKET, BY REGION

8.1 OVERVIEW 40

8.2 AMERICAS 40

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.2.1 NORTH AMERICA 42

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.2.1.1 US 44

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.2.1.2 CANADA 45

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.2.2 LATIN AMERICA 46

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3 EUROPE 47

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1 WESTERN EUROPE 49

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1.1 GERMANY 51

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1.2 FRANCE 52

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1.3 UK 53

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1.4 ITALY 54

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1.5 SPAIN 55

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.1.6 REST OF WESTERN EUROPE 56

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.3.2 EASTERN EUROPE 57

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4 ASIA-PACIFIC 58

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4.1 JAPAN 60

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4.2 CHINA 61

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4.3 INDIA 62

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4.4 SOUTH KOREA 63

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4.5 AUSTRALIA 64

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.4.6 REST OF ASIA-PACIFIC 65

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.5 MIDDLE EAST & AFRICA 67

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.5.1 MIDDLE EAST 69

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

8.5.2 AFRICA 70

PERFUSION RADIOLOGY MARKET, BY APPLICATION

PERFUSION RADIOLOGY MARKET, BY END USER

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 71

9.2 COMPETITIVE BENCHMARKING 72

9.3 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PERFUSION RADIOLOGY MARKET 73

9.4 KEY DEVELOPMENT ANALYSIS 73

9.4.1 PARTNERSHIP/STRATEGIC AGREEMENT 74

9.4.2 ACQUISITIONS 74

9.5 PRODUCT APPROVALS 75

9.6 EXPANSIONS 75

10 COMPANY PROFILES

10.1 GE HEALTHCARE 76

10.1.1 COMPANY OVERVIEW 76

10.1.2 FINANCIAL OVERVIEW 77

10.1.3 PRODUCTS/SERVICES OFFERED 78

10.1.4 GE HEALTHCARE: KEY DEVELOPMENTS 78

10.1.5 SWOT ANALYSIS 79

10.1.6 KEY STRATEGIES 79

10.2 SIEMENS 80

10.2.1 COMPANY OVERVIEW 80

10.2.2 FINANCIAL OVERVIEW 80

10.2.3 PRODUCTS/SERVICES OFFERED 81

10.2.4 KEY DEVELOPMENTS 81

10.2.5 SWOT ANALYSIS 82

10.2.6 KEY STRATEGIES 82

10.3 CANON MEDICAL SYSTEMS CORPORATION 83

10.3.1 COMPANY OVERVIEW 83

10.3.2 FINANCIAL OVERVIEW 83

10.3.3 PRODUCTS/SERVICES OFFERED 84

10.3.4 KEY DEVELOPMENTS 84

10.3.5 SWOT ANALYSIS 85

10.3.6 KEY STRATEGIES 85

10.4 BRACCO DIAGNOSTIC, INC. 86

10.4.1 COMPANY OVERVIEW 86

10.4.2 FINANCIAL OVERVIEW 86

10.4.3 PRODUCTS/SERVICES OFFERED 87

10.4.4 KEY DEVELOPMENTS 87

10.4.5 SWOT ANALYSIS 87

10.4.6 KEY STRATEGIES 87

10.5 KONINKLIJKE PHILIPS NV 88

10.5.1 COMPANY OVERVIEW 88

10.5.2 FINANCIAL OVERVIEW 89

10.5.3 PRODUCTS/SERVICES OFFERED 90

10.5.4 KEY DEVELOPMENTS 91

10.5.5 SWOT ANALYSIS 91

10.5.6 KEY STRATEGIES 91

10.6 SHIMADZU CORPORATION 92

10.6.1 COMPANY OVERVIEWS 92

10.6.2 FINANCIAL OVERVIEW 92

10.6.3 PRODUCTS/SERVICES OFFERED 93

10.6.4 KEY DEVELOPMENTS 93

10.6.5 SWOT ANALYSIS 93

10.6.6 KEY STRATEGIES 94

10.7 LANTHEUS MEDICAL IMAGING, INC. 95

10.7.1 COMPANY OVERVIEW 95

10.7.2 FINANCIAL OVERVIEW 95

10.7.3 PRODUCTS/SERVICES OFFERED 96

10.7.4 KEY DEVELOPMENTS 96

10.7.5 SWOT ANALYSIS 96

10.7.6 KEY STRATEGIES 96

10.8 PERIMED 97

10.8.1 COMPANY OVERVIEW 97

10.8.2 FINANCIAL OVERVIEW 97

10.8.3 PRODUCTS/SERVICES OFFERED 97

10.8.4 KEY DEVELOPMENTS 97

10.8.5 SWOT ANALYSIS 98

10.8.6 KEY STRATEGIES 98

10.9 NEUSOFT CORPORATION 99

10.9.1 COMPANY OVERVIEW 99

10.9.2 FINANCIAL OVERVIEW 100

10.9.3 PRODUCTS/SERVICES OFFERED 101

10.9.4 KEY DEVELOPMENTS 101

10.9.5 SWOT ANALYSIS 101

10.9.6 KEY STRATEGIES 102

10.10 ADVANTIS MEDICAL IMAGING 103

10.10.1 COMPANY OVERVIEW 103

10.10.2 FINANCIAL OVERVIEW 103

10.10.3 PRODUCTS/SERVICES OFFERED 103

10.10.4 KEY DEVELOPMENTS 103

10.10.5 SWOT ANALYSIS 104

10.10.6 KEY STRATEGIES 104

11 APPENDIX

11.1 REFERENCES 105

11.2 RELATED REPORTS 106

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 15

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

TABLE 3 GLOBAL PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 31

TABLE 4 GLOBAL PERFUSION RADIOLOGY MARKET FOR CARDIOVASCULAR IMAGING, BY REGION, 2020–2027 (USD MILLION) 32

TABLE 5 GLOBAL PERFUSION RADIOLOGY MARKET FOR VENTILATION IMAGING, BY REGION, 2020–2027 (USD MILLION) 33

TABLE 6 GLOBAL PERFUSION RADIOLOGY MARKET FOR BRAIN IMAGING, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 7 GLOBAL PERFUSION RADIOLOGY MARKET FOR OTHERS, BY REGION, 2020–2027 (USD MILLION) 35

TABLE 8 GLOBAL PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 36

TABLE 9 GLOBAL PERFUSION RADIOLOGY MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 10 GLOBAL PERFUSION RADIOLOGY MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 11 GLOBAL PERFUSION RADIOLOGY MARKET FOR OTHERS, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 12 AMERICAS: PERFUSION RADIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 13 AMERICAS: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 41

TABLE 14 AMERICAS: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 41

TABLE 15 NORTH AMERICA: PERFUSION RADIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 42

TABLE 16 NORTH AMERICA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 43

TABLE 17 NORTH AMERICA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 43

TABLE 18 US: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44

TABLE 19 US: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 44

TABLE 20 CANADA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 45

TABLE 21 CANADA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 45

TABLE 22 LATIN AMERICA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 46

TABLE 23 LATIN AMERICA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 46

TABLE 24 EUROPE: PERFUSION RADIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 25 EUROPE: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 48

TABLE 26 EUROPE: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 48

TABLE 27 WESTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 49

TABLE 28 WESTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 50

TABLE 29 WESTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 50

TABLE 30 GERMANY: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51

TABLE 31 GERMANY: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 51

TABLE 32 FRANCE: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 52

TABLE 33 FRANCE: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 52

TABLE 34 UK: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53

TABLE 35 UK: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 53

TABLE 36 ITALY: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54

TABLE 37 ITALY: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 54

TABLE 38 SPAIN: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 55

TABLE 39 SPAIN: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 55

TABLE 40 REST OF WESTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 41 REST OF WESTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 56

TABLE 42 EASTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57

TABLE 43 EASTERN EUROPE: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 57

TABLE 44 ASIA-PACIFIC: PERFUSION RADIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 45 ASIA-PACIFIC: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 46 ASIA-PACIFIC: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 60

TABLE 47 JAPAN: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 48 JAPAN: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 61

TABLE 49 CHINA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61

TABLE 50 CHINA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 51 INDIA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 52 INDIA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 63

TABLE 53 SOUTH KOREA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 54 SOUTH KOREA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 55 AUSTRALIA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 64

TABLE 56 AUSTRALIA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 65

TABLE 57 REST OF ASIA-PACIFIC: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 58 REST OF ASIA-PACIFIC: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 66

TABLE 59 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 67

TABLE 60 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 61 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 68

TABLE 62 MIDDLE EAST: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 69

TABLE 63 MIDDLE EAST: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 69

TABLE 64 AFRICA: PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 65 AFRICA: PERFUSION RADIOLOGY MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 66 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PERFUSION IMAGING MARKET 73

TABLE 67 PARTNERSHIP/STRATEGIC AGREEMENT 74

TABLE 68 ACQUISITIONS 74

TABLE 69 PRODUCT APPROVALS 75

TABLE 70 EXPANSIONS 75

TABLE 71 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 78

TABLE 72 KEY DEVELOPMENTS 78

TABLE 73 SIEMENS: PRODUCTS/SERVICES OFFERED 81

TABLE 74 SIEMENS: KEY DEVELOPMENTS 81

TABLE 75 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS/SERVICES OFFERED 84

TABLE 76 CANON MEDICAL SYSTEMS CORPORATION: KEY DEVELOPMENTS 84

TABLE 77 BRACCO DIAGNOSTIC INC.: PRODUCTS/SERVICES OFFERED 87

TABLE 78 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 90

TABLE 79 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 91

TABLE 80 SHIMADZU CORPORATION: PRODUCTS/SERVICES OFFERED 93

TABLE 81 SHIMADZU CORPORATION: KEY DEVELOPMENTS 93

TABLE 82 LANTHEUS MEDICAL IMAGING, INC.: PRODUCTS/SERVICES OFFERED 96

TABLE 83 MEDA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 97

TABLE 84 NEUSOFT CORPORATION: PRODUCTS/SERVICES OFFERED 101

TABLE 85 ADVANTIS MEDICAL IMAGING: PRODUCTS/SERVICES OFFERED 103

13 LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 12

FIGURE 2 GLOBAL PERFUSION RADIOLOGY MARKET: STRUCTURE 15

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 20

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERFUSION RADIOLOGY MARKET 23

FIGURE 5 DRIVER IMPACT ANALYSIS 25

FIGURE 6 RESTRAINT IMPACT ANALYSIS 26

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PERFUSION RADIOLOGY MARKET 27

FIGURE 8 VALUE CHAIN ANALYSIS OF THE GLOBAL PERFUSION RADIOLOGY MARKET 29

FIGURE 9 GLOBAL PERFUSION RADIOLOGY MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 31

FIGURE 10 GLOBAL PERFUSION RADIOLOGY MARKET, BY END USER, 2020 & 2027 (USD MILLION) 36

FIGURE 11 AMERICAS: PERFUSION RADIOLOGY MARKET SHARE, BY REGION 2020 (%) 40

FIGURE 13 EUROPE: PERFUSION RADIOLOGY MARKET SHARE, BY REGION 2020 (%) 47

FIGURE 14 WESTERN EUROPE: PERFUSION RADIOLOGY MARKET SHARE, BY COUNTRY2020 (%) 49

FIGURE 15 ASIA-PACIFIC: PERFUSION RADIOLOGY MARKET SHARE, BY COUNTRY2020 (%) 58

FIGURE 16 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET SHARE, BY REGION2020 (%) 67

FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS 72

FIGURE 18 PERFUSION IMAGING MARKET, COMPETITIVE LANDSCAPE (% SHARE) 73

FIGURE 19 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 77

FIGURE 20 GE HEALTHCARE: SWOT ANALYSIS 79

FIGURE 21 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 80

FIGURE 22 SIEMENS: SWOT ANALYSIS 82

FIGURE 23 CANON MEDICAL SYSTEMS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 83

FIGURE 24 CANON MEDICAL SYSTEMS CORPORATION: SWOT ANALYSIS 85

FIGURE 25 BRACCO DIAGNOSTIC INC.: FINANCIAL OVERVIEW SNAPSHOT 86

FIGURE 26 BRACCO DIAGNOSTIC INC.: SWOT ANALYSIS 87

FIGURE 27 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 89

FIGURE 28 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 91

FIGURE 29 SHIMADZU CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 92

FIGURE 30 SHIMADZU CORPORATION: SWOT ANALYSIS 93

FIGURE 31 LANTHEUS MEDICAL IMAGING, INC.: FINANCIAL OVERVIEW SNAPSHOT 95

FIGURE 32 LANTHEUS MEDICAL IMAGING, INC.: SWOT ANALYSIS 96

FIGURE 33 PERIMED: SWOT ANALYSIS 98

FIGURE 34 NEUSOFT CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 100

FIGURE 35 NEUSOFT CORPORATION: SWOT ANALYSIS 101

FIGURE 36 ADVANTIS MEDICAL IMAGING: SWOT ANALYSIS 104



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.